A patent review of topoisomerase I inhibitors (2016–present)-Reference-Cited by-同舟云学术

A patent review of topoisomerase I inhibitors (2016–present)

Published:2021-04-29 Issue:6 Volume:31 Page:473-508
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Selas Asier¹,Martin-Encinas Endika¹,Fuertes Maria¹,Masdeu Carme¹,Rubiales Gloria¹,Palacios Francisco¹,Alonso Concepción¹

Affiliation:

1. Departamento De Química Orgánica I, Facultad De Farmacia. Universidad Del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Vitoria-Gasteiz, Spain

Funder

Ministerio de Ciencia, Innovación y Universidades

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2021.1879051

Reference144 articles.

1. Human DNA topoisomerase I: relaxation, roles, and damage control

2. The long story of camptothecin: From traditional medicine to drugs

3. DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition

4. DNA topoisomerase I from parasitic protozoa: A potential target for chemotherapy

5. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers;Drug Design, Development and Therapy;2024-06

2. Experimental and computational study on anti-gastric cancer activity and mechanism of evodiamine derivatives;Frontiers in Pharmacology;2024-05-07

3. Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review;Cancers;2024-02-06

4. DNA topoisomerases as a drug target in Leishmaniasis: Structural and mechanistic insights;International Journal of Biological Macromolecules;2024-01

5. Design, Synthesis, and Anticancer Evaluation of Hemithioindigos via Inhibition of Human Topoisomerases;ChemistrySelect;2023-11-05